Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanis Roussel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Internal Medicine|July 1, 2020
Chloroquine and COVID-19: A western medical and scientific drift?Matthieu Million, Yanis Roussel, Didier Raoult
Lancet (London, England)|June 18, 2019
Alcohol and the global burden of diseaseCedric Abat, Yanis Roussel, Hervé Chaudet, et al.
International Journal of Antimicrobial Agents|January 7, 2021
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysisMatthieu Million, Yanis Roussel, Philippe Gautret, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 27, 2020
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et alMatthieu Million, Yanis Roussel, Jean-Christophe Lagier, et al.
The Lancet. Infectious Diseases|February 7, 2019
Attributable deaths caused by infections with antibiotic-resistant bacteria in FranceDidier Raoult, Marc Leone, Yanis Roussel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2020
Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United StatesYanis Roussel, Matthieu Million, Eric Chabriere, et al.
International Journal of Antimicrobial Agents|January 7, 2021
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literaturePhilippe Gautret, Van Thuan Hoang, Stéphane Honoré, et al.
International Journal of Antimicrobial Agents|March 24, 2020
SARS-CoV-2: fear versus dataYanis Roussel, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, et al.
Travel Medicine and Infectious Disease|May 11, 2020
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceMatthieu Million, Jean-Christophe Lagier, Philippe Gautret, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Internal Medicine|July 1, 2020
Chloroquine and COVID-19: A western medical and scientific drift?Matthieu Million, Yanis Roussel, Didier Raoult
Lancet (London, England)|June 18, 2019
Alcohol and the global burden of diseaseCedric Abat, Yanis Roussel, Hervé Chaudet, et al.
International Journal of Antimicrobial Agents|January 7, 2021
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysisMatthieu Million, Yanis Roussel, Philippe Gautret, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 27, 2020
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et alMatthieu Million, Yanis Roussel, Jean-Christophe Lagier, et al.
The Lancet. Infectious Diseases|February 7, 2019
Attributable deaths caused by infections with antibiotic-resistant bacteria in FranceDidier Raoult, Marc Leone, Yanis Roussel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2020
Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United StatesYanis Roussel, Matthieu Million, Eric Chabriere, et al.
International Journal of Antimicrobial Agents|January 7, 2021
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literaturePhilippe Gautret, Van Thuan Hoang, Stéphane Honoré, et al.
International Journal of Antimicrobial Agents|March 24, 2020
SARS-CoV-2: fear versus dataYanis Roussel, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, et al.
Travel Medicine and Infectious Disease|May 11, 2020
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceMatthieu Million, Jean-Christophe Lagier, Philippe Gautret, et al.
Pageof 1